» Articles » PMID: 23016698

High-quality CMV-specific CD4+ Memory is Enriched in the Lung Allograft and is Associated with Mucosal Viral Control

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2012 Sep 29
PMID 23016698
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The maintenance of CMV-specific T cell memory in lung transplant recipients (LTRs) is critical for host defense and allograft durability, particularly in donor(+) /recipient(-) (D(+) R(-) ) individuals who demonstrate increased mortality. We studied CD4(+) and CD8(+) CMV-specific memory responses to phosphoprotein 65 (pp65) in a prospective cohort of 18 D(+) R(-) LTRs, from bronchoalveolar lavage (BAL)-obtained lung mononuclear cells (LMNC) and PBMC. Unexpectedly, pp65-specific CD4(+) and CD8(+) IFN-γ memory responses from LMNC were similar, in contrast to persistent CD8(+) predominance in PBMC. Unlike the pulmonary CD8(+) predominance during acute primary infection, compartmental equalization occurred in the CMV-specific CD8(+) memory pool during chronic infection, whereas CMV-specific CD4(+) memory was enriched in the bronchoalveolar space. Moreover, CMV-specific CD4(+) memory T cells with multifunctional production of IFN-γ, TNF-α, IL-2 and MIP-1β were significantly increased in LMNCs, in contrast to similar intercompartmental CD8(+) memory function. Moreover, the absolute number of CMV-specific CD4(+) IFN-γ(+) memory cells in BAL was significantly increased in LTRs exhibiting viral control compared to those with CMV early antigen positivity. Collectively, these data demonstrate both preferential distribution and functional quality of CMV-specific CD4(+) memory in the lung allograft during chronic infection, and show an important association with CMV mucosal immunity and viral control.

Citing Articles

Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword.

Bharti R, Calabrese D Front Transplant. 2024; 3:1388393.

PMID: 38993763 PMC: 11235306. DOI: 10.3389/frtra.2024.1388393.


CD4 T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent.

Popescu I, Snyder M, Iasella C, Hannan S, Koshy R, Burke R Am J Respir Crit Care Med. 2022; 205(12):1403-1418.

PMID: 35348444 PMC: 9875894. DOI: 10.1164/rccm.202111-2493OC.


Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies.

Xiu M, Liu Z, Tang J Int Immunopharmacol. 2020; 87:106827.

PMID: 32791489 PMC: 7417178. DOI: 10.1016/j.intimp.2020.106827.


Early KLRG1 but Not CD57CD8 T Cells in Primary Cytomegalovirus Infection Predict Effector Function and Viral Control.

Hoji A, Popescu I, Pipeling M, Shah P, Winters S, McDyer J J Immunol. 2019; 203(8):2063-2075.

PMID: 31554693 PMC: 7081945. DOI: 10.4049/jimmunol.1900399.


Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection.

Gordon C, Miron M, Thome J, Matsuoka N, Weiner J, Rak M J Exp Med. 2017; 214(3):651-667.

PMID: 28130404 PMC: 5339671. DOI: 10.1084/jem.20160758.


References
1.
Masopust D, Vezys V, Marzo A, Lefrancois L . Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001; 291(5512):2413-7. DOI: 10.1126/science.1058867. View

2.
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401(6754):708-12. DOI: 10.1038/44385. View

3.
Pipeling M, West E, Osborne C, Whitlock A, Dropulic L, Willett M . Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection. J Immunol. 2008; 181(1):546-56. PMC: 2668691. DOI: 10.4049/jimmunol.181.1.546. View

4.
Purton J, Tan J, Rubinstein M, Kim D, Sprent J, Surh C . Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med. 2007; 204(4):951-61. PMC: 2118539. DOI: 10.1084/jem.20061805. View

5.
Zamora M . Cytomegalovirus and lung transplantation. Am J Transplant. 2004; 4(8):1219-26. DOI: 10.1111/j.1600-6143.2004.00505.x. View